Log In
Print
BCIQ
Print
Print this Print this
 

OMS103, OMS103HP

  Manage Alerts
Collapse Summary General Information
Company Omeros Corp.
DescriptionCombination of ketoprofen, amitriptyline and oxymetazoline added to standard arthroscopic irrigation solutions
Molecular Target
Mechanism of Action 
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPhase III
Standard IndicationPain
Indication DetailsReduce pain following arthroscopic partial meniscectomy surgery
Regulatory Designation
Partner Fagron N.V.

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

1

$10.0M

0

$10.0M


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone
Get a free BioCentury trial today